115 related articles for article (PubMed ID: 7477761)
1. Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in the rat striatum.
Jolkkonen J; Granata R; Jenner P; Marsden CD
Neuropeptides; 1995 Aug; 29(2):109-14. PubMed ID: 7477761
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.
Granata R; Wenning GK; Jolkkonen J; Jenner P; Marsden CD
J Neural Transm (Vienna); 1996; 103(3):249-60. PubMed ID: 8739837
[TBL] [Abstract][Full Text] [Related]
3. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
Paul ML; Currie RW; Robertson HA
Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
[TBL] [Abstract][Full Text] [Related]
4. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine.
Nisenbaum LK; Kitai ST; Gerfen CR
Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
Pollack AE; Wooten GF
Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
[TBL] [Abstract][Full Text] [Related]
7. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
8. Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.
Cauli O; Pinna A; Morelli M
Behav Pharmacol; 2005 Dec; 16(8):621-6. PubMed ID: 16286813
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
Engber TM; Boldry RC; Kuo S; Chase TN
Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580
[TBL] [Abstract][Full Text] [Related]
10. Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C.
Simpson CS; Morris BJ
Neuroscience; 1995 Sep; 68(1):97-106. PubMed ID: 7477939
[TBL] [Abstract][Full Text] [Related]
11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons.
Laprade N; Radja F; Reader TA; Soghomonian JJ
J Neurosci; 1996 Jun; 16(11):3727-36. PubMed ID: 8642415
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
14. Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease.
Carta A; Fenu S; Morelli M
Neurol Sci; 2001 Feb; 22(1):59-60. PubMed ID: 11487201
[TBL] [Abstract][Full Text] [Related]
15. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
[TBL] [Abstract][Full Text] [Related]
16. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
Garrett BE; Holtzman SG
Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
[TBL] [Abstract][Full Text] [Related]
17. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
18. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
19. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
20. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.
Mattingly BA; Rowlett JK; Lovell G
Psychopharmacology (Berl); 1993; 110(3):320-6. PubMed ID: 7831425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
